ANGPTL4

angiopoietin like 4, the group of Angiopoietin like family|Fibrinogen C domain containing

Basic information

Region (hg38): 19:8363289-8374370

Links

ENSG00000167772NCBI:51129OMIM:605910HGNC:16039Uniprot:Q9BY76AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANGPTL4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANGPTL4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
4
clinvar
6
missense
19
clinvar
4
clinvar
1
clinvar
24
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
3
4
non coding
1
clinvar
1
Total 0 0 19 6 6

Variants in ANGPTL4

This is a list of pathogenic ClinVar variants found in the ANGPTL4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-8364338-C-A not specified Uncertain significance (Apr 24, 2024)3294204
19-8364346-G-A not specified Uncertain significance (Oct 06, 2021)2376899
19-8364410-C-A not specified Uncertain significance (Dec 28, 2022)2340159
19-8364439-G-A Plasma triglyceride level quantitative trait locus association (May 08, 2009)4712
19-8364441-G-A Likely benign (May 15, 2018)744498
19-8364507-C-T ANGPTL4-related disorder Benign (Mar 29, 2019)3042853
19-8364522-C-G ANGPTL4-related disorder Likely benign (Jul 01, 2019)3042507
19-8364532-C-T not specified Uncertain significance (Oct 11, 2023)3118667
19-8366033-A-G not specified Uncertain significance (Jan 26, 2022)3118675
19-8366196-TC-T Benign (May 20, 2018)783818
19-8366269-C-T not specified Uncertain significance (Oct 02, 2023)3118677
19-8366293-C-T not specified Uncertain significance (Oct 03, 2022)2251997
19-8366310-C-T not specified Uncertain significance (Nov 18, 2022)2222719
19-8369213-C-T Benign (Jun 12, 2018)730728
19-8369216-C-T Benign (May 20, 2018)783819
19-8369219-G-T not specified Uncertain significance (May 27, 2022)2292984
19-8369300-C-T not specified Uncertain significance (Aug 05, 2023)2616585
19-8369301-G-A ANGPTL4-related disorder Benign (Nov 26, 2019)3041796
19-8369320-A-T Plasma triglyceride level quantitative trait locus association (Jan 01, 2009)139626
19-8371103-T-G not specified Uncertain significance (Oct 29, 2021)2361664
19-8371109-C-T not specified Uncertain significance (Feb 23, 2023)2468828
19-8371237-C-G ANGPTL4-related disorder Likely benign (Apr 09, 2019)3047940
19-8371297-C-T not specified Uncertain significance (Jun 18, 2024)3294200
19-8371298-G-A not specified Uncertain significance (Jan 04, 2024)3118695
19-8371316-G-A Benign (Jun 21, 2018)768962

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANGPTL4protein_codingprotein_codingENST00000301455 711085
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.31e-110.13412563601121257480.000445
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4392272460.9210.00001512610
Missense in Polyphen9899.4590.985331127
Synonymous0.601981060.9260.00000628809
Loss of Function0.5701820.80.8650.00000118185

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003600.000359
Ashkenazi Jewish0.001200.00119
East Asian0.00005440.0000544
Finnish0.0004280.000416
European (Non-Finnish)0.0006400.000633
Middle Eastern0.00005440.0000544
South Asian0.0001650.000163
Other0.0004910.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Protein with hypoxia-induced expression in endothelial cells. May act as a regulator of angiogenesis and modulate tumorigenesis. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. May exert a protective function on endothelial cells through an endocrine action. It is directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity. In response to hypoxia, the unprocessed form of the protein accumulates in the subendothelial extracellular matrix (ECM). The matrix-associated and immobilized unprocessed form limits the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibits their adhesion. It also decreases motility of endothelial cells and inhibits the sprouting and tube formation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12015030, ECO:0000269|PubMed:14583458}.;
Pathway
Cholesterol metabolism - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;PPAR signaling pathway;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein remodeling (Consensus)

Intolerance Scores

loftool
0.837
rvis_EVS
0.11
rvis_percentile_EVS
61.91

Haploinsufficiency Scores

pHI
0.0674
hipred
N
hipred_score
0.170
ghis
0.420

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.382

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Angptl4
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; immune system phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype;

Zebrafish Information Network

Gene name
angptl4
Affected structure
endothelial cell
Phenotype tag
abnormal
Phenotype quality
increased occurrence

Gene ontology

Biological process
angiogenesis;response to hypoxia;regulation of lipid metabolic process;cell differentiation;negative regulation of apoptotic process;positive regulation of angiogenesis;negative regulation of lipoprotein lipase activity;protein homooligomerization;triglyceride homeostasis;negative regulation of endothelial cell apoptotic process
Cellular component
extracellular region;extracellular space;blood microparticle
Molecular function
enzyme inhibitor activity;protein binding;identical protein binding